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Abstract
Introduction Poor road and communication infrastructure
pose major challenges to tuberculosis (TB) control in many
regions of the world. TB surveillance and patient support
often fall to community health workers (CHWs) who may
lack the time or knowledge needed for this work. To
meet the End TB Strategy goal of reducing TB incidence
by 90% by 2035, the WHO calls for intensified research
and innovation including the rapid uptake of new tools,
interventions and strategies. Technologies that ‘leapfrog’
infrastructure challenges and support CHWs in TB control
responsibilities have the potential to dramatically change
TB outcomes in remote regions. Such technologies may
strengthen TB control activities within challenged national
tuberculosis treatment and control programmes (NTPs),
and be adapted to address other public health challenges.
The deployment of innovative technologies needs to
be differentially adapted to context-specific factors.
The Drone Observed Therapy System (DrOTS) project
was launched in Madagascar in 2017 and integrates a
bundle of innovative technologies including drones, digital
adherence monitoring technology and mobile devicebased educational videos to support TB control.
Methods and analysis This mixed-methods study
gathers and analyses cultural perceptions of the
DrOTS project among key stakeholders: patients,
community members, CHWs, village chiefs and NTP–
DrOTS mobile health teams. Data from questionnaires,
semistructured interviews, focus group discussions
(FGD) and ethnographic observation gathered from
June 2018 to June 2019 are thematically analysed and
compared to identify patterns and singularities in how
DrOTS stakeholders perceive and interact with DrOTS
technologies, its enrolment processes, objectives and
team.
Ethics and dissemination Ethics approval was obtained
from the National Bioethics Research Committee of
Madagascar and Stony Brook University institutional
review board. Study results will be submitted for peerreviewed publication. In Madagascar, results will be
presented in person to Ministry and other Malagasy

Strengths and limitations of this study
►► This study is one of the first to assess acceptance

and perceptions of drones and evriMED pillboxes
(medication reminder and digital remote treatment adherence monitoring devices), technologies
currently being considered for scale-up in several
health systems around the world. The bundle of
technologies at the core of this study is one that
could be applied in response to other health needs
in other contexts.
►► Qualitative methods facilitate detailed and nuanced
understanding of how and why stakeholders with
limited literacy and in remote settings perceive and
use new technologies.
►► Data are collected from a range of stakeholders and
focused on those using these new technologies on
the front-lines in low-income countries (ie, patients,
national mobile healthcare team members, community health workers and villagers).
►► Findings from perception studies serve to deepen
understanding of how contextual particularities can
impact on acceptance, perceptions of and interactions with new technologies but may not be generalisable across distinct settings and populations.

decision-makers through the Institut Pasteur de
Madagascar.
Patient and public involvement This study is designed
to foreground the voices of patients and potential patients
in the DrOTS programme. CHW participants in this study
also supported the design of study information sessions
and recruitment strategies. One member of the mobile
health team provided detailed input on the wording and
content of FGD and interview guides. Study findings will
be presented via a report in French and Malagasy to CHW,
mobile health team and other village-level participants
who have email/internet access.
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with local community health workers (CHWs). DrOTS
implements active case finding and supports TB
screening, diagnosis, counselling and treatment supervision within communities using a suite of technologies:
drones, evriMED pillboxes and tablet-based educational
videos. In this scheme, drones increase access to diagnosis
and care by facilitating specimen transport and securing
the medication supply chain between diagnosis and treatment centres and remote communities; the evriMED
supports TB treatment adherence and monitoring by
beeping when patients need to take their medication,
and tracking for healthcare providers when the evriMED
has been opened (equated with dose being taken); and a
tablet-based eHealth video curriculum supports patients
and CHWs by providing key information on TB care and
prevention at every step of the pathway to cure. Given
the novelty of this approach, we designed and presented
here a study protocol for the DrOTS perception study, a
mixed-method cultural acceptability substudy embedded
within the DrOTS project.
Several organisations are exploring the economic
and practical feasibility of using drones for healthcare
purposes including support to rescue missions in disasters; enhanced epidemiological monitoring for disease
outbreaks and vectors; delivery of critical resources such
as blood or defibrillators in emergencies; delivery of other
routine and occasional medical payloads such as samples
for laboratory analysis, vaccines, medication and supplies
for community healthcare centres.13–18 Medication
reminder and remote treatment adherence monitoring
devices, such as the evriMED pillbox, may augment treatment adherence and facilitate more effective allocation
of limited healthcare personnel resources in contexts
where populations are hard to reach, or health systems
under-resourced.19–21 While the potential of new digital
technologies to transform healthcare is enormous, this
potential is contingent on user-specific and context-specific needs, engagements with technologies and digital
health strategies, and may imply different impacts and
challenges in different contexts.22
This study will shed light on cultural and individual
perceptions, barriers and facilitators to implementation of the unique bundle of technologies that make up
the DrOTS system. To facilitate the implementation of
such innovative technologies, other challenges such as
sustained funding, creation of an LMIC-friendly market
environment for drone supplies and aviation regulation
approval also need to be overcome: such barriers are not
addressed here.
Rationale
Determining the success of the DrOTS project cannot
be limited to evaluation of its impacts on additional TB
notifications or completed treatments. Though such
measures are central to establishing the value and potential of innovative technologies in the global fight against
TB, the success of innovative public health strategies is
also contingent on how those on the receiving end of
Nouvet E, et al. BMJ Open 2019;9:e028073. doi:10.1136/bmjopen-2018-028073
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Introduction
Ten million people developed active tuberculosis (TB)
disease in 2017.1 To meet the End TB Strategy goal of
reducing incidence by 90% and mortality by 95% before
2035, the WHO has called for intensified research and
innovation including the rapid uptake of new tools, interventions and strategies.2 In low-income and middle-income countries (LMIC) that are disproportionately more
affected by disease, TB control can be hindered by any
number of social and structural factors, including limited
access to centralised facilities for populations living outside
the capital, understaffed healthcare infrastructures, poor
development of laboratory diagnostic networks or stigma
influencing healthcare seeking behaviours and treatment
adherence.3 4 In such contexts, diagnosis may be delayed
or fail to occur at all, and implementation of TB control
essential strategies such as case finding, access to laboratory diagnosis, directly observed therapy and contact
tracing by national tuberculosis control programmes
(NTPs) becomes particularly challenging, increasing
secondary transmission and fatalities.5
In 2017, nearly 30 000 TB cases were reported in Madagascar.6 This corresponds to half of actual cases to have
occurred in the country, as estimated by WHO.6 Treatment
adherence and success rates are reported to be highly
variable between regions of the country, respectively,
averaging 60% and 84% in the Drone Observed Therapy
System (DrOTS) intervention area and at national level.6 7
Madagascar exemplifies the challenges of quality TB care
delivery for remote and dispersed populations as 40% of
Malagasy people live more than 5 km from the nearest
basic healthcare facility, with no public transit system or
even roads in many cases.8 TB diagnosis and treatment
challenges in Madagascar are representative of those in
many areas of sub-Saharan Africa: (i) underserved healthcare system; (ii) poverty and cultural norms hindering
healthcare seeking; (iii) paucity of human resource
capacities with training in TB; (iv) paucity of diagnostic
facilities; (v) suboptimal coverage of treatment and treatment follow-up and (vi) high prevalence of two important
TB risk factors, that is, malnutrition and indoor air pollution.5 7 9 10 Conversely, factors of good prognosis for TB
control in Madagascar include very low rates of both
multi-drug resistant TB (MDR-TB) infection and HIV-TB
coinfection in the country.6 11
To leapfrog over theses impediments to quality TB care,
the DrOTS project was coinitiated with the Malagasy NTP
and was deployed by Stony Brook University’s Global
Health Institute in collaboration with the Institut Pasteur
de Madagascar. The project was implemented in 61
randomly selected villages in Androrangavola commune,
south-eastern Madagascar, in August 2017. Up to 70%
of the approximately 27 000 inhabitants living in Androrangavola commune live more than 5 km away from the
closest healthcare facility, and that facility in turn is situated more than 1 day’s walk from the closest TB diagnosis
centre.12 DrOTS involves an NTP–DrOTS mobile health
team consisting of TB nurses and doctors who collaborate
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Primary objectives
1. To identify prevalent perceptions (eg, perceived benefits, concerns, misunderstandings) related to the various technological and programmatic aspects of the
DrOTS project at the level of TB patients, members
of patient households, other village members, CHWs,
village chiefs and NTP–DrOTS mobile health team.
2. To generate a description of how and why individuals,
families and villages are interacting with specific components of the DrOTS project in unanticipated ways.

Secondary objectives
1. To establish rates and demographic distribution of
understandings of and interactions with the various
technological and programmatic aspects of the DrOTS
project.
2. To generate understandings of how and based on what
factors individuals, families and villages are deciding
whether or not to participate in the DrOTS project.
3. To develop a set of evidence-based cultural and contextual considerations that can inform the implementation of similar technology-mediated diagnostic and
treatment in other regions of Madagascar and in other
national contexts.
Methods and analysis
Study design
The DrOTS perception study is a mixed-methods study
involving cross-sectional data collection through (i)
questionnaires (~750), (ii) focus group discussions
FGDs (~19), (iii) semistructured in-depth interviews
(~24) and (iv) ethnographic observation (figure 1).
Quantitative questionnaire data are collected throughout
the DrOTS project period (November 2017–December
2018) as well as an additional 6-month after project end
for follow-up of TB patients adhering to a 6-month treatment regimen. Data collection for the qualitative part is
initiated in June 2018 with a first village visit, followed by
second and third village in August and November 2018,
respectively. Ethnographic observation occurs between
June and July 2018. All study tools were developed by
content experts in dialogue with members of the DrOTS

Figure 1 Timelines, approaches and tools, DrOTS perception study, Madagascar, 2017–2019. DrOTS, Drone Observed
Therapy System; TB, tuberculosis.
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these perceive and engage with its objectives, enrolment,
participation processes and technologies. The DrOTS
perception study aims to build expertise on how to
implement new technologies in a way that is acceptable
to individuals and communities that lack close or affordable access to TB diagnosis and treatment, have no prior
exposure to such technologies and may harbour understandings of TB that limit management of presumptive
or confirmed infections. Attending to these contextual
and lived particularities of the DrOTS project is key to
designing and planning feasible and effective scale-up.
Recently published WHO guidelines will certainly help
TB control programmes choosing and implementing
digital adherences monitoring technologies.22 At present,
there exists no ethical or practical guidance on the
contextually sensitive use of such technologies or for the
use of drones for disease diagnosis and treatment. This
study can inform needed evidence-based guidance for
the future expansion of such technology suites poised to
strengthen TB programmes and healthcare systems more
generally.

Open access

Questionnaire survey
The use of the questionnaire survey in this mixed-methods
study aims to support measurement and comparison
of key acceptability indicators between different study
subgroups (eg, patients vs non-patients, most educated
vs least educated). The questionnaire is being administered to different groups including patients, members of
patient households, other village members, CHWs, village
chiefs and NTP–DrOTS mobile health teams.
Two questionnaires are being used: (i) DrOTS baseline
questionnaire conducted with presumptive and confirmed
TB cases, other village members and CHWs (see online
supplementary material 1—DrOTS Perception Study
Baseline Questionnaire), and (ii) DrOTS end-of-treatment questionnaire conducted with confirmed TB
cases (see online supplementary material 2—DrOTS
Perception Study End-of-Treatment Questionnaire).
Questionnaires are administered verbally by members
of the NTP–DrOTS mobile health team to 10–15 individuals aged ≥15 years in each of the DrOTS-participating
villages, amounting to a total of around 750 completed
baseline questionnaires. The sample size was calculated
based on (i) a total population size of 27 000 in Androrangavola commune, (ii) on the assumption that 50%
reply ‘Yes’ to one main question on drone perception (ie,
‘Do you think that the drones bring something positive to
your community?’, (iii) a 95% confidence level and (iv) a
10% drop-out rate. This resulted in a sample size of 417.
However, the overall DrOTS-project design, lifespan and
geographic coverage allowed us to sample a larger population. All self-presenting presumptive (including later
confirmed) TB cases and CHWs are purposively invited
to answer the baseline questionnaire, with remaining
participants being randomly recruited in each DrOTS
village. This questionnaire provides quantitative data on
basic sociodemographic characteristics, travel history, TB
risk factors, TB-related health seeking behaviour, medical
history, knowledge on TB and behaviours towards TB.
An end-of-treatment questionnaire is administered to all
enrolled TB patients on completion of treatment. This
questionnaire addresses specific perceptions of drones,
evriMED and educational videos. Questionnaire data are
collected using tablet-based Open Data Kit (ODK) software standardised form.
Focus group discussions
FGD-based qualitative data collection is taking place in
three of the 61 DrOTS participating villages as well as
with the NTP–DrOTS mobile health team. Villages for
the running of FGDs are selected based on1 participation
in the DrOTS project for at least 3 months2; accessibility
for the qualitative research team, meaning within a day’s
hike from the closest vehicle-accessible town3 and willingness to host the DrOTS perception team. Collecting
4

data in three villages enables comparison of reported
perceptions and acceptability of new technologies across
villages, the possibility for diversity in perceptions to be
captured. Furthermore, even where similarities exist, a
more nuanced understanding of how village-specific characteristics, such as access to livelihood activities, norms of
postsecondary education achievement and historical relations to outsiders travelling in the region (eg, for mining
or development initiatives) may shape perceptions of the
DrOTS project.
Sampling of FGD participants is purposive and
randomised. It is purposive inasmuch as we are aiming
to gather perceptions from a range of individuals who
have engaged with DrOTS first-hand. For FGDs, we also
aim to have an equal representation of men and women,
and an equal representation across age groups in villages,
towards capturing potential diversity in experiences of
DrOTS based on diverse levels or types of responsibility
in the home and village. Villagers willing to partake in
a FGD provide their names to the research team, and
may or may not be randomly selected to join the FGD
organised for their age and gender group. Randomised
selection of village FGD participants avoids burdening
CHWs or other leaders with the task of identifying potential participants (which could also potentially result in
biased responses tied to particular village interests). Also,
in our experience, many are interested in participating
in FGDs, and this randomised selection ensures all those
interested have and know they have an equal chance of
being selected (names of volunteers drawn from hat at
village meeting).
Homosociality and age-group separation are dominant norms guiding social interaction in this part of
Madagascar. Hence, to facilitate participants feeling at
ease and to limit the possibility of social hierarchies in
a FGD over-determining who feels able to express their
view in a group, FGDs are being organised along age and
gender lines: married men, married women, unmarried
men, unmarried women, elder men and elder women
(table 1). FGDs are run using a standard set of questions
organised into two parts. Part I focuses on deepening
the understanding of the participants’ day-to-day definition and management of illness and understandings of
TB prior to DrOTS and part II focuses on perceptions
and interactions with DrOTS. The set of questions for
the NTP–DrOTS mobile health team FGD is distinct, and
probes members’ understanding and concerns related to
DrOTS, as well as perceptions of cultural and village-specific attitudes, knowledge and engagements with specific
aspects of DrOTS pilot project based on work in all
villages (see online supplementary material 3—DrOTS
Perception Study FGD Guide). All FGDs are moderated
and/or supervised by an experienced medical anthropologist and conducted in Malagasy local dialect with the
help of a translator. With participants’ permission, these
are digitally recorded.
Nouvet E, et al. BMJ Open 2019;9:e028073. doi:10.1136/bmjopen-2018-028073
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team responsible for community engagement and/or
familiar with local dialect and customs in Androrangavola
commune.
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Table 2 Semistructured interview recruitment plan, DrOTS
perception study, Madagascar, 2017–2019

Location

Stakeholder group

Target
no
groups

Village 1

Unmarried women
Unmarried men

1
1

4
4

Married women

1

4

Married men

1

4

Villagers hesitant, unable or 2
who have declined DrOTS
participation

Elderly women

1

4

Community health worker

1

Village leaders

1
8

Village 2

Village 3

Location
Participants/
group

Elderly men

1

4

Unmarried women

1

4

Unmarried men

1

4

Married women

1

4

Married men

1

4

Elderly women

1

4

Elderly men

1

4

Unmarried women

1

4

Unmarried men

1

4

Married women

1

4

Married men

1

4

Elderly women

1

4

Elderly men

1

4

1

5

19

77

National TB Mobile health unit
Programme team members
Total

DrOTS, Drone Observed Therapy System; TB, tuberculosis.

Semistructured in-depth interviews
Semistructured in-depth interviews gather information on different stakeholders’ knowledge of, attitudes
towards, uses and first-hand experiences of the DrOTS
project that cannot be gleaned from questionnaires,
and may be too sensitive or detailed to emerge in FGDs
(online supplementary material 4—DrOTS Perception
Study SemiStructured Interview Guide). Recruitment
is purposive and targets five categories of key stakeholders in each village 1) DrOTS project-enrolled adult
patients (over 15 years of age) 2) adults who presented
for TB testing to the DrOTS team but have received negative diagnostic testing results 3) villagers hesitant, unable
or have declined to join the project 4) CHWs 5) village
leaders, including kings and elected district chiefs. All
participants except for participants from category 3 are
being identified with help from the NTP–DrOTS mobile
team. Participants in category 3 are invited to self-identify
in the process of FGDs and may be identified by other
interview participants using ‘snowball sampling’. An estimated eight interviews will be performed in the same
subset of three villages as FGDs for a total of 24 interviews
(table 2). Additional interviews are performed with TB
Nouvet E, et al. BMJ Open 2019;9:e028073. doi:10.1136/bmjopen-2018-028073

Stakeholder group

Sample village DrOTS enrolled patient
Villagers who tested
negative for TB

Total

Participants
2
2

DrOTS, Drone Observed Therapy System; TB, tuberculosis.

confirmed cases outside the included villages to increase
the number of DrOTS-enrolled patients.
Ethnographic observation
An anthropology trainee will seek permission to stay with
one DrOTS patient in their village over a 2-week period
in order to better understand, through ethnographic
observation, how that individual lives with TB disease on
a daily basis and interacts with DrOTS. The trainee will
keep a record of what they notice and learn (field notes),
attending to 1) ways in which patients, villagers, village
leaders, the CHW in the village, or any members of the
mobile health team present in this 2-week period discuss
DrOTS with the patient or one another, 2) technical,
practical community or individual level challenges, 3) any
differences or similarities in attitudes or beliefs about the
DrOTS pilot project study expressed in informal conversation about the project and/or its technologies and 4)
contextualised information about how the patient at the
centre of this observation views and uses DrOTS technologies. Ethnographic observation often occurs over a
period of months or even years; however, even shorter
applications of this method can build contextual understanding of healthcare projects. Use of this method in
this study may confirm or reveal gaps in the information
gathered through the other data collection methods, and
serve to identify questions for future research.
Analysis
Questionnaire quantitative data will be descriptively analysed using STATA V.14.0 (StataCorp; Texas, USA) and
will address and compare levels of acceptability between
groups.
Interviews and FGDs will be transcribed and translated into English by a professional Malagasy translator
mastering the field study site local dialect. Transcripts
will be uploaded into Nvivo V.12.0 (QSR; Melbourne,
Australia) and be subjected to thematic analysis. Categories of enquiry in interview and FGD guides will form the
basis for an initial coding structure. Three semistructured
interviews will then be independently coded by two investigators to test and adjust this structure in light of the data,
5
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perception study, Madagascar, 2017–2019
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Dissemination
Following project and technology sensitisation visits and
in accordance with cultural norms, consent is obtained
from the local leaders to present this research project to
villagers under their responsibility before engaging in
any activities within villages. Though limited literacy is
widespread in this region of Madagascar, as per national
research ethics norm, consent forms are read and
explained to participants and written informed consent
is obtained from any and all parties agreeing to participate before conducting interviews, focus groups and
observations. Data are being anonymised rendering
participants’ identification from dissemination material
impossible. Participants in this perceptions study do not
face any different healthcare as a result of participation.
All patients diagnosed with TB within the DrOTS projects
are treated for free in accordance with NTP and WHO
guidelines.
One issue that requires managing in such a study is the
risk of social stigma for participants. TB and association
with TB are stigmatised in contexts around the world, and
well documented in sub-Saharan Africa (eg,3 4 23–25 While
there is no evidence of TB stigma in the Malagasy context
of our research, we are adopting strategies to mitigate the
risk of TB-related stigma developing for participants in
our TB-focused study. In our initial meeting with CHWs
in each village, we are stressing our interest in speaking
with DrOTS-enrolled patients (TB active) but also our
commitment to keeping the TB-active status of these
patients private. We will be working with CHWs in villages
to identify strategies to protect the TB-active status of any
patients we interview. In presenting the study to the entire
village, we are stressing our interest in understanding the
villagers’—and not just presumptive or confirmed TB positive individuals’—perceptions of the DrOTS programme.
The number of individuals, including respected elders,
and range of visible healthiness of those who are participating in either an interview or FGD in each village
does reduce the possibility of a single individual among
a village’s participants being associated with TB. We will
not carry out the ethnographic observation component
of this study if doing so risks rendering public a currently
private TB diagnosis.
6

Results of the DrOTS perception study will be submitted
for peer-review publication. A two-page summary of results
will be prepared in French and Malagasy and included
as an appendix to the results paper, and shared with
participants and collaborators for whom we have contact
information. In Madagascar, results will be presented in
person to Ministry and other Malagasy decision-makers
through the Institut Pasteur de Madagascar.
Discussion
This study responds to a current gap in knowledge on the
feasibility and cultural acceptability of using a new suite of
technologies including evriMED, drones and tablet-mediated video education to support improved TB diagnosis
and treatment in remote populations. Digital technologies that enable remote monitoring and faster delivery of
medical care and supplies are potential game changers
for healthcare landscapes struggling with long-standing
or temporary (eg, due to disasters) barriers to healthcare
delivery. Still, the development of innovative healthcare
technologies does not guarantee their enthusiastic and
rapid adoption in diverse settings.26–28 Perceived benefits
and risks, use and challenges of adopting such innovation
is not likely to be uniform across distinct sociocultural,
health system and economic settings. These may vary
depending on any number of factors, including (to name
just a few) the presence or lack of alternative options for
care, association of use with a context-specific stigmatised
condition, as well as prior direct or rumoured experiences with interventions deemed to be similar in some
way to the new ones. There is inherent ethical complexity
in using devices such as drones for ‘surgical strikes’ on
‘wicked’ global health challenges, if key determinants
of poor health remain unaddressed.29 Recent studies
conducted with intended users and ‘beneficiaries’ of
new digital health systems in LMIC contexts reveal other
context-specific and culture-specific concerns or limitations of these technologies, such as concerns these could
dehumanise assistance,28 infringe on private spaces30 and
be too expensive for some governments.30 Findings from
the DrOTS cultural acceptability study may or may not
reveal similar concerns in the Malagasy context, and will
be situated within growing literature on perceptions and
acceptability of TB remote digital medical monitoring
and adherence strategies.
While focused on one project in Madagascar, the
DrOTS perception study provides a model for attending
to contextual factors that may affect target population
support and intended interactions with any number of
other new public health initiatives around the world.
Embedding such perception studies within projects is
particularly important for initiatives conceptualised based
on the theoretical but as of yet unproven potential of new
technologies. While findings from perceptions studies on
new innovative technology-mediated health projects may
not be readily generalisable, as each setting is unique,
such studies can generate learning that is transferable to
Nouvet E, et al. BMJ Open 2019;9:e028073. doi:10.1136/bmjopen-2018-028073
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adding themes to account for unanticipated but relevant
content. In an iterative process, minor adjustments and
additions (eg, change in theme names or merging of
themes) to the codebook will be made when needed. Key
theme and subtheme contents will be summarised and
reviewed to allow linkage of quantitative and qualitative
data, clearly identify themes with exemplary quotes, raise
questions and concerns, and inform guidelines for culturally and contextually sensitive technology implementations. Ethnographic field notes will not be coded but
will inform the analysis by providing support to findings
from the interviews and FGDs, and/or by identifying gaps
knowledge gaps.
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Limitations and potential challenges
The significance of results from this study will be difficult
to ascertain given limited research on drone supported TB
or other public health programmes at this juncture. Future
research on similar programmes introduced in Madagascar
or elsewhere will be helpful in assessing the generalisability
of our eventual results to other regions and populations
where such technologies for increased healthcare provision
are being introduced. This study does not include interviews or FGDs with National TB programme policy-makers
and decision-makers. Understanding rationales underlying government approval of pilot programmes such as
DrOTS among individuals working for national TB control
in the country, as well as the challenges and perception of
outcomes and impact among these stakeholders constitute
equally important research as we work towards clarifying
what it means to develop context-appropriate use of innovative technologies in TB control.
Respondents may overemphasise positive perceptions of
DrOTS. Social desirability bias is a challenge in perceptions
studies, especially where there may be unspoken assumption
among participants that their responses to study questions
could negatively impact future programmes.31 Our work
across multiple villages will increase our ability to detect
and probe overly positive accounts from participants. We
are confident in the study’s design and its ability to generate
accurate and detailed insight into perceptions of DrOTS;
however, we recognise the possibility that with a focus on
only three of the 61 DrOTS-enrolled villages, our qualitative
data collection may not capture the full range of perceptions
that may be present among Malagasy villagers enrolled in
DrOTS.
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